The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union.
| Publicado en: | Clinical Chemistry Vol. 65; no. 2; pp. 242 - 254 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
Oxford University Press / USA
Feb2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=134541259&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 134541259 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00099147 10CS jtl: Clinical Chemistry issn: 00099147 maglogo: N pubinfo: dt: Feb2019 vid: 65 iid: 2 pid: 622 pub: Oxford University Press / USA artinfo: ui: 134541259 10.1373/clinchem.2017.281626 134541259 ppf: 242 ppct: 12 formats: fmt: @attributes: type: P tig: atl: The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union. aug: au: Jannetto, Paul J. Helander, Anders Garg, Uttam Janis, Gregory C. Goldberger, Bruce Ketha, Hemamalini affil: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|